Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
38,512,859
-
Total 13F shares
-
24,001,384
-
Share change
-
-69,718
-
Total reported value
-
$33,602,029
-
Price per share
-
$1.40
-
Number of holders
-
37
-
Value change
-
-$48,851
-
Number of buys
-
10
-
Number of sells
-
13
Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) as of Q1 2024
As of 31 Mar 2024 Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) had 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 24,001,384 shares of stock of the company.
Largest 10 holders included Vivo Capital, LLC, TANG CAPITAL MANAGEMENT LLC, Sofinnova Investments, Inc., CITADEL ADVISORS LLC, Pivotal bioVenture Partners Investment Advisor LLC, Newtyn Management, LLC, ORBIMED ADVISORS LLC, Nan Fung Group Holdings Ltd, Samsara BioCapital, LLC, and VANGUARD GROUP INC.
This table shows 37 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.